Metraipolis › archive › dc_5ff8aa04db4c

Evaluation of accuracy and performance of self-reported HIV and antiretroviral therapy status in the Nigeria AIDS Indicator and Impact Survey (2018) — Europe PMC PMID:36037201

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36037201
DOI
10.1371/journal.pone.0273748
License (as archived)
CC0-1.0
Archived
2026-10-16T23:14:25.075Z
SHA-256 of the archived text
97f537677ebbca49d371b27bf10f368163a22c3435af46a0072631a544742d1c
Stable URL of this page
https://metraipolis.com/documento/dc_5ff8aa04db4c

How to cite

Evaluation of accuracy and performance of self-reported HIV and antiretroviral therapy status in the Nigeria AIDS Indicator and Impact Survey (2018) — Europe PMC PMID:36037201 — Europe PMC (en), https://europepmc.org/article/MED/36037201 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_5ff8aa04db4c (Metraipolis archive dc_5ff8aa04db4c, sha256 97f537677ebbca49d371b27bf10f368163a22c3435af46a0072631a544742d1c)
BibTeX
@misc{dc5ff8aa04db4c,
  title = {Evaluation of accuracy and performance of self-reported HIV and antiretroviral therapy status in the Nigeria AIDS Indicator and Impact Survey (2018) — Europe PMC PMID:36037201},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36037201},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_5ff8aa04db4c; sha256 97f537677ebbca49d371b27bf10f368163a22c3435af46a0072631a544742d1c},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/36037201. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Data on awareness of HIV status among people living with HIV (PLHIV) are critical to estimating progress toward epidemic control. To ascertain the accuracy of self-reported HIV status and antiretroviral drug (ARV) use in the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS), we compared self-reported HIV status with HIV rapid diagnostic test (RDT) results and self-reported ARV use with detectable blood ARV levels. Methods: On the basis of responses and test results, participants were categorized by HIV status and ARV use. Self-reported HIV status and ARV use performance characteristics were determined by estimating sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Proportions and other analyses were weighted to account for complex survey design. Results: During NAIIS, 186,405 participants consented for interview out of which 58,646 reported knowing their HIV status. Of the 959 (weighted, 1.5%) who self-reported being HIV-positive, 849 (92.1%) tested HIV positive and 64 (7.9%) tested HIV negative via RDT and polymerase chain reaction test for discordant positive results. Of the 849 who tested HIV positive, 743 (89.8%) reported using ARV and 72 (10.2%) reported not using ARV. Of 57,687 who self-reported being HIV negative, 686 (1.2%) tested HIV positive via RDT, with ARV biomarkers detected among 195 (25.1%). ARV was detected among 94.5% of those who self-reported using ARV and among 42.0% of those who self-reported not using ARV. Overall, self-reported HIV status had sensitivity of 52.7% (95% confidence interval [CI]: 49.4%-56.0%) with specificity of 99.9% (95% CI: 99.8%-99.9%). Self-reported ARV use had sensitivity of 95.2% (95% CI: 93.6%-96.7%) and specificity of 54.5% (95% CI: 48.8%-70.7%). Conclusions: Self-reported HIV status and ARV use screening tests were found to be low-validity measures during NAIIS. Laboratory tests to confirm self-reported information may be necessary to determine accurate HIV and clinical status for HIV studies in Nigeria.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2022 (prima pubblicazione 2022-08-29).
Identificativi: PMID 36037201 · PMCID PMC9423665 · DOI 10.1371/journal.pone.0273748.
Descrittori MeSH principali: HIV Infections; Acquired Immunodeficiency Syndrome.
Pagina: https://europepmc.org/article/MED/36037201 — https://doi.org/10.1371/journal.pone.0273748. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-16T22:52:12.552Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.